World's Best Scientists 2026 revealed!
Régis Bataille

Régis Bataille

D-Index & Metrics

Medicine

D-Index
97
Citations
41000
World Ranking
9166
National Ranking
277

Overview

Régis Bataille is affiliated with the University of Angers in France and primarily conducts research within the medical field. Their scholarly contributions focus extensively on hematology and related subfields such as hepatology, immunology, and genetics.

The main topics covered in Régis Bataille's work include:

  • Multiple Myeloma Research and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Liver Physiology and Pathology
  • Immunotherapy and Immune Responses
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Régis Bataille has published research papers in several peer-reviewed journals. Recent publications include:

  • "Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory," 2020, published in Cancers
  • "The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis," 2023, published in Biology
  • "A bone paradigm challenging the standard model of myeloma oncogenesis," 2022, published in Critical Reviews in Oncology/Hematology

Among collaborators, Jean-Pascal Capp is a frequent co-author, having worked together on multiple publications related to myeloma research.

The primary publication venues where Régis Bataille's research appears include:

  • Cancers
  • Biology
  • Critical Reviews in Oncology/Hematology

The scientist's work is situated within medicine, with a strong emphasis on hematology, accounting for the majority of their publications. Research in hepatology, immunology, and genetics also contribute to the diversity of their academic exploration.

Best Publications

  • A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

    Michel Attal;Jean-Luc Harousseau;Anne-Marie Stoppa;Jean-Jacques Sotto

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

    Michel Attal;Jean-Luc Harousseau;Thierry Facon;François Guilhot

  • Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

    Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel

  • Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

    Bernard Klein;Xue-Guang Zhang;Michel Jourdan

  • Genetics and Cytogenetics of Multiple Myeloma A Workshop Report

    Rafael Fonseca;Bart Barlogie;Regis Bataille;Christian Bastard

  • Interleukin-6 in human multiple myeloma.

    B. Klein;Xue-Guang Zhang;Zhao-Yang Lu;R. Bataille

  • Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

    Philippe Moreau;Thierry Facon;Michel Attal;Cyrille Hulin

  • Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.

    R. Bataille;M. Jourdan;Xue-Guang Zhang;B. Klein

  • Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

    Sophie Derenne;Brett Monia;Nicholas M. Dean;Jennifer K. Taylor

  • Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

    Joseph T. Beck;Su-Ming Hsu;John Wijdenes;Regis Bataille

  • Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

    Nicola Giuliani;Régis Bataille;Cristina Mancini;Mirca Lazzaretti

  • Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome

    Olivier Decaux;Laurence Lodé;Florence Magrangeas;Catherine Charbonnel

  • Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

    Hervé Avet-Loiseau;Thierry Facon;Bernard Grosbois;Florence Magrangeas

  • Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma

    Regis Bataille;Bart Barlogie;Zhao Yang Lu;Jean-Franpois Rossi

  • Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

    Philippe Moreau;Thierry Facon;Xavier Leleu;Nadine Morineau

  • Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.

    S. Wuilleme-Toumi;N. Robillard;P. Gomez;P. Moreau

  • C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.

    R Bataille;M Boccadoro;B Klein;B Durie

  • Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

    Thierry Facon;Hervé Avet-Loiseau;Gaëlle Guillerm;Philippe Moreau

  • Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma

    XG Zhang;B Klein;R Bataille

Frequent Co-Authors

Jean-Luc Harousseau
Jean-Luc Harousseau University of Nantes
Thierry Facon
Thierry Facon Centre Hospitalier Régional et Universitaire de Lille
Michel Attal
Michel Attal Janssen (Belgium)
John Wijdenes
John Wijdenes Grenoble Alpes University
Philippe Moreau
Philippe Moreau University of Nantes
Denis Caillot
Denis Caillot Grenoble Alpes University
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
Xueguang Zhang
Xueguang Zhang Soochow University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in health care but looking for alternatives to traditional medical school, a variety of online degrees offer flexible pathways into related professions. For example, those who want to work in mental health nursing may consider fast track mental health nursing programs, which prepare graduates for specialist roles in a fraction of the time.

Healthcare management is another in-demand field. Earning a health administration degree online can open doors to operational and leadership roles in hospitals and clinics. Those seeking even higher-level positions may pursue one of the cheapest mha programs, adding strategic and policy expertise to their resume.

Current nurses aiming for advanced practice should consider msn to dnp programs online, which help nurses become clinical experts and leaders in the field. These options offer flexible, affordable paths to rewarding and impactful health care careers beyond becoming a physician.

Best Scientists Citing Régis Bataille

Trending Scientists